第7章 中國市場中Lumbrokinase的主要製藥公司

第8章 中國的Lumbrokinase的市場預測

市場規模的預測

競爭情形的預測

目錄

Product Code: 1508294

Lumbrokinase is a fibrinolytic enzyme present in the earthworm Lumbricus bimastus. Currently, it has been widely used for the prevention and treatment of cardiovascular diseases, endocrine diseases and respiratory diseases due to its efficacy of improving blood circulation.

The number of patients suffering from cardiovascular disease has kept rising to over 270 million in China by the end of 2013. With ageing population in China, the incidence of cardiovascular has kept rising, rendering its prevention and treatment quite important. As lumbrokinase can improves blood calculation and prevent cerebral thrombosis, it will enjoy a large market in the future. Besides, with economic development and severe environmental problems, cardiovascular diseases, endocrine diseases and respiratory diseases have reported increasing incidence, which also promotes the market demand for lumbrokinase.

Lumbrokinase boasts of a large and stable market demand. According to CRI's market survey, lumbrokinase sales in Chinese sample hospitals has dropped from CNY 54 million in 2010 to CNY 43.39 million in 2014. And in 2014, Beijing Baiao Pharmaceuticals Co., Ltd had the largest market share of about 29% for sales value.

Readers can get at least the following information from this report:

market size of lumbrokinase in China

competitive landscape of lumbrokinase in Chinese market

price of lumbrokinase made by different enterprises in China

market outlook of lumbrokinase in China

The author suggests the following groups of people purchase this report: